The procedure takes forty minutes. You arrive at a Neuralink-certified surgical center, you are placed under local anesthesia, and a robot the size of a sewing machine drills 64 electrode threads — each one thinner than a human hair — through your skull and into the motor cortex. You go home the same day. By morning, you are calibrating.

The N2 is not a medical device. It is not a research instrument. It is a consumer product that lets you control software with your mind, and after three weeks of daily use, the most alarming thing about it is how quickly it stops feeling alarming. The first time you move a cursor by thinking about moving your hand, it is extraordinary. By day four, it is just how you use a computer. By day ten, using a mouse feels like typing with oven mitts on.

What the N2 Actually Is

The N2 is Neuralink's second-generation implant, released commercially in Q1 2026 following FDA clearance for healthy adults. The first generation, the N1, was limited to paralyzed patients under compassionate use protocols. The N2 is available to anyone over 21 who can pass a neurological screening and afford the $19,500 procedure cost, which is not yet covered by any major insurer.

The hardware is a coin-sized titanium disc, the Link, implanted flush with the skull behind the right ear. It communicates wirelessly with a receiver worn as a small adhesive patch on the same side of the head. The patch connects via Bluetooth to any device running the Neuralink SDK — currently iOS, Android, macOS, Windows, and a growing ecosystem of third-party applications. Battery life is 24 hours. Charging is inductive, through the skin, while you sleep.

The 64 electrode threads read local field potentials from approximately 1,024 neurons in the hand and finger regions of the motor cortex. The on-device processor — a custom ASIC running at 1 GHz — decodes these signals in real time and translates them into cursor movement, click events, scroll commands, and a growing library of gesture primitives. The latency from neural signal to device response is under 5 milliseconds. For context: the latency from your finger touching a trackpad to a cursor moving on screen is approximately 20 milliseconds.

The Calibration Experience

The first session is humbling. You sit in front of a screen displaying a moving target and you think about moving your hand toward it. Nothing happens. Then something happens — a twitch, a drift, a suggestion of movement. The system is learning your neural signature, and you are learning to produce it consistently. It takes about forty minutes for the first session to feel like control rather than coincidence.

By day three, the calibration has converged. The system has built a decoder model specific to your neural patterns, and the cursor moves where you intend it to move with an accuracy that, on standard Fitts's Law benchmarks, exceeds what most people achieve with a mouse. Not because the interface is faster in absolute terms, but because the intention-to-action loop has been shortened by one step: you no longer need to translate a mental command into a physical movement. The mental command is the movement.

This is the thing that is difficult to convey in a review. The N2 does not feel like using a tool. It feels like the tool has become part of your body. The cursor is, experientially, an extension of your hand — not a proxy for it. The phenomenology of the interface is categorically different from any previous human-computer interaction paradigm, and that difference is not subtle once you have experienced it.

The Sovereignty Question

The N2 raises questions that no previous consumer technology has raised, because no previous consumer technology has been implanted in your brain.

Neuralink's privacy policy states that neural data is processed on-device and that only decoded command signals — cursor coordinates, click events — are transmitted to connected devices. Raw neural data never leaves the implant. This is the correct architecture, and it is verifiable in principle through hardware inspection and firmware auditing, which Neuralink has committed to allowing through a third-party security research program that has not yet produced public results.

The firmware update question is more complex. The N2 receives over-the-air firmware updates automatically, and there is no mechanism to opt out of updates without disabling the device entirely. You are, in other words, running software in your brain that can be changed by the manufacturer at any time, for any reason, subject only to FDA oversight of the update process. This is not a hypothetical concern. It is the current state of the product.

For the deeper philosophical framing of what it means to have a persistent AI layer modeling your neural patterns, our AI Identity pillar is the right starting point. The N2 is the most literal instantiation of the questions that pillar explores. The NeuroRights Foundation at Columbia University is doing the most serious legal and ethical work on the governance framework this technology requires. The FDA's AI/ML-enabled medical device framework is the current regulatory context, and it was not designed for this.

The Neural Mesh Horizon

The N2 reads from 1,024 neurons. The theoretical upper bound of the current electrode thread architecture is approximately 10,000 neurons per implant. Beyond that, the bottleneck is not the electrodes — it is the bandwidth available to transmit decoded signals from the implant to external devices. The next generation of this technology will require photonic interconnects to move neural data at the speeds that high-bandwidth brain-computer interfaces demand. We covered the infrastructure layer of this transition in our piece on neural mesh and the coming BCI stack.

The N2 is, in this sense, the iPhone 1 of brain-computer interfaces. Remarkable for what it is. Primitive relative to what it will become. The category it has opened is real, and it will not close.

The Verdict

The Neuralink N2 is the most significant human-computer interface since the touchscreen. The performance is real, the latency is genuinely lower than any previous input device, and the phenomenology of direct neural control is unlike anything else in consumer technology.

It is also a surgical procedure, a permanent implant, and a firmware-updatable device running in your motor cortex. The decision to get one is not a consumer decision. It is a decision about what kind of relationship you want to have with your own nervous system, and with the company that will be maintaining the software running inside it for the rest of your life.

For the right person — someone with a clear professional use case, a high tolerance for frontier risk, and a considered position on the sovereignty questions — the N2 is transformative. For everyone else, wait for the governance framework to catch up with the technology. It will not take long.

Neuralink N2 — $19,500 (procedure + hardware). Available at certified surgical centers. Reviewed over 21 days of daily use on macOS 16 and iOS 20.